JP Morgan Maintains Overweight on Insulet, Lowers Price Target to $162
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Insulet (NASDAQ:PODD) but lowered the price target from $325 to $162.
October 17, 2023 | 4:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan has maintained an Overweight rating on Insulet but lowered the price target from $325 to $162.
The lowering of the price target by JP Morgan indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100